glp-1 biosimilar Agonists Market Report 2025-2033, By Product, Molecule, and Geo From GLP-1 Black Market to
Description
Glucagon-like peptide-1 (GLP-1) is a pleiotropic hormone that has a broad role in metabolism regulation, including the stimulation of insulin secretion and appetite suppression (Muller et al., 2019), both of which contribute to diabetes treatment
More stable blood sugar means fewer crash hunger episodes and less urgent need for emergency snacks
For instance, Kaiser Permanente plans to revise its coverage criteria starting January 1, 2025, leading to inquiries about whether Kaiser covers weight loss drugs, as it will exclude coverage for GLP-1 medications when prescribed exclusively for reducing body mass in patients with a BMI under 40
Takeda J, Seino Y, Tanaka K, et al
The study also showed that these medicines prevented the weight gain side effect of quitting smoking
There is also substantial impact on overall lifespan with an estimated 520 years of life lost for individuals with a BMI 45 [9]
